Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Aptevo Therapeutics Inc APVO

Healthcare Biotechnology
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel bispecific immunotherapies for the treatment of cancer. The Company has two clinical candidates: Mipletamig and ALG.APV-527. Mipletamig is being evaluated in RAINIER, a two-part Phase 1b/2 trial for the treatment of frontline acute myeloid leukemia in combination with standard-of-care venetoclax... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:APVO)

RAINIER Trial Data Update: Two Additional AML Patients Achieve Remission Within 30 Days of Treatment

ACCESS Newswire 3 days ago

Aptevo Highlights APVO603: A Novel Bispecific Antibody Targeting 4-1BB and OX40 for Enhanced Solid Tumor Immunotherapy

ACCESS Newswire 5 days ago

Aptevo to Participate in March Conferences

ACCESS Newswire March 6, 2025

Aptevo Therapeutics Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESS Newswire February 15, 2025

Aptevo Therapeutics Reports 2024 Financial Results And Provides A Business Update

ACCESS Newswire February 14, 2025

Aptevo's Peter Pavlik, PhD, Chairing Session on "Bi and Multispecific Biologics" at Cambridge Healthcare Institute's Pep Talk 2025

ACCESS Newswire January 15, 2025

Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds

ACCESS Newswire December 12, 2024

100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline AML Trial

ACCESS Newswire December 12, 2024

Bispecific Antibody, APVO442, Differentiated to Treat Prostate Cancer with Precision Tumor Targeting and Reduced Risk of Side Effects

ACCESS Newswire December 4, 2024
View More News ››

Opinion & Analysis (NDAQ:APVO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:APVO)

RE:APVO....just alittle over 1 month since my last post on this

APVO traded at $4 this a.m.....I'm still here so show me the money Honey Waiting for the major move North Cheers !
Iseneschal - February 28, 2025

APVO....just alittle over 1 month since my last post on this

Starting a position today.... $3.30 Whack the bid Mr. M......I need some cheap paper. Thanks in advance ; )
Iseneschal - February 20, 2025

APVO....just tapped N.H.O.D $5.30

Any seller ???? Haha
Iseneschal - January 6, 2025

APVO.....N.H.O.D this a.m at $5.03

Better than a poke in the eye with a sharp stick
Iseneschal - January 6, 2025

APVO.....back on the W/L for next week

$4.50 Have grrrrreat weekend
Iseneschal - January 3, 2025

APVO.....Can it get any worse....$5.78 now

You bet your sweet bippy it can....2morrow is another day All the Bagholders can call IR for their free Xmas Turkey Vouchers Hurry...
Iseneschal - December 12, 2024
View more Bullboard ››

Africa Oil Corp.

Africa Oil Corp.

Africa Oil Corp. is a Canadian oil and gas company with producing and development assets in deepwater Nigeria, an interest in ...
View More »